APA (7th ed.) Citation

Kolinger, G. D., Sotolongo-Grau, O., Roé-Vellvé, N., Tartari, J. P., Sanabria, Á., Pérez-Martínez, E., . . . Alllué, J. A. (2025). Quantification of baseline amyloid PET in individuals with subjective cognitive decline can identify risk of amyloid accumulation and cognitive worsening: The FACEHBI study. European Journal of Nuclear Medicine & Molecular Imaging, 52(10), 3578. https://doi.org/10.1007/s00259-025-07270-7

Chicago Style (17th ed.) Citation

Kolinger, Guilherme Domingues, et al. "Quantification of Baseline Amyloid PET in Individuals with Subjective Cognitive Decline Can Identify Risk of Amyloid Accumulation and Cognitive Worsening: The FACEHBI Study." European Journal of Nuclear Medicine & Molecular Imaging 52, no. 10 (2025): 3578. https://doi.org/10.1007/s00259-025-07270-7.

MLA (9th ed.) Citation

Kolinger, Guilherme Domingues, et al. "Quantification of Baseline Amyloid PET in Individuals with Subjective Cognitive Decline Can Identify Risk of Amyloid Accumulation and Cognitive Worsening: The FACEHBI Study." European Journal of Nuclear Medicine & Molecular Imaging, vol. 52, no. 10, 2025, p. 3578, https://doi.org/10.1007/s00259-025-07270-7.